All lobbying filings
W STRATEGIES, LLC
W STRATEGIES, LLC filed a Q1 report for SUPERNUS PHARMACEUTICALS FKA SAGE THERAPEUTICS on April 18, 2025, reporting $50,000 in lobbying income.
Lobbying for SUPERNUS PHARMACEUTICALS FKA SAGE THERAPEUTICS · A clinical-stage biopharmaceutical company.
Filing · LD-2 quarterly report
Q1 report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 18, 2025
Income
$50,000
What the client paid this registrant for the period.
Client based in
Massachusetts
Lobbying activity
1
Education and awareness of mental health issues especially as it relates to access for postpartum depression treatment and major depressive disorder.